Universal versus genotype-guided use of direct oral anticoagulants in atrial fibrillation patients: a decision analysis. (Q50950032)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26230572%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

Universal versus genotype-guided use of direct oral anticoagulants in atrial fibrillation patients: a decision analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26230572%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

0 references

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26230572%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Joyce H S You

series ordinal

1

1 reference

25 March 2018

http://europepmc.org/abstract/MED/26230572

publication date

31 July 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26230572%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26230572%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26230572%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26230572%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

1089-1100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26230572%20AND%20SRC:MED&resulttype=core&format=json

Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range

20 February 2020

cites work

1 reference

Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation?

21 January 2018

1 reference

Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population

21 January 2018

1 reference

Estimation of the warfarin dose with clinical and pharmacogenetic data

21 January 2018

1 reference

Warfarin dosing algorithm using clinical, demographic and pharmacogenetic data from Chinese patients.

21 January 2018

1 reference

A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II).

21 January 2018

1 reference

A randomized trial of genotype-guided dosing of warfarin.

21 January 2018

1 reference

A pharmacogenetic versus a clinical algorithm for warfarin dosing

21 January 2018

1 reference

Dabigatran versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

Apixaban versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

21 January 2018

1 reference

New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis

21 January 2018

1 reference

Cost effectiveness of treatments for stroke prevention in atrial fibrillation: focus on the novel oral anticoagulants

21 January 2018

1 reference

Cost-effectiveness of dabigatran versus genotype-guided management of warfarin therapy for stroke prevention in patients with atrial fibrillation

21 January 2018

1 reference

Cost-effectiveness of pharmacogenetics-guided warfarin therapy vs. alternative anticoagulation in atrial fibrillation.

21 January 2018

1 reference

Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study).

21 January 2018

1 reference

Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.

21 January 2018

1 reference

Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis

21 January 2018

1 reference

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

21 January 2018

1 reference

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

21 January 2018

1 reference

Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin

21 January 2018

1 reference

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

21 January 2018

1 reference

Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis

21 January 2018

1 reference

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

21 January 2018

1 reference

Death and disability from warfarin-associated intracranial and extracranial hemorrhages

21 January 2018

1 reference

Effect of aspirin and warfarin on early survival after intracerebral haemorrhage

21 January 2018

1 reference

Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation

21 January 2018

1 reference

Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation

21 January 2018

1 reference

The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors.

21 January 2018

1 reference

Preference-Based EQ-5D index scores for chronic conditions in the United States

21 January 2018

1 reference

Long-term economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: results from the Treating to New Targets (TNT) Trial

21 January 2018

1 reference

Cost-effectiveness of pravastatin therapy for survivors of myocardial infarction with average cholesterol levels

21 January 2018

1 reference

Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study

21 January 2018

1 reference

Comparison of assay systems for warfarin-related CYP2C9 and VKORC1 genotyping

21 January 2018

1 reference

New allele-specific real-time PCR system for warfarin dose genotyping equipped with an automatic interpretative function that allows rapid, accurate, and user-friendly reporting in clinical laboratories

21 January 2018

1 reference

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

21 January 2018

1 reference

Cost-effectiveness of oral anticoagulants for treatment of atrial fibrillation

21 January 2018

1 reference

Novel oral anticoagulants versus warfarin therapy at various levels of anticoagulation control in atrial fibrillation--a cost-effectiveness analysis.

21 January 2018

1 reference

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: a Canadian payer perspective.

21 January 2018

1 reference

Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems

21 January 2018

1 reference

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

21 January 2018

1 reference

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

21 January 2018

1 reference

National patterns of risk-standardized mortality and readmission for acute myocardial infarction and heart failure. Update on publicly reported outcomes measures based on the 2010 release

21 January 2018

1 reference

Telephone versus office-based management of warfarin: impact on international normalized ratios and outcomes

21 January 2018

1 reference

Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study

21 January 2018

1 reference

Supervised patient self-testing of warfarin therapy using an online system

21 January 2018

1 reference

Quality of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation in the community setting.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/PGS.15.64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26230572%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference